Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,746 | 957 | 99.8% |
| Education | $16.97 | 4 | 0.1% |
| Entertainment | $13.24 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,475 | 107 | $0 (2024) |
| Lilly USA, LLC | $1,338 | 83 | $0 (2024) |
| ABBVIE INC. | $1,245 | 73 | $0 (2024) |
| GlaxoSmithKline, LLC. | $966.90 | 89 | $0 (2024) |
| Novo Nordisk Inc | $952.87 | 66 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $856.54 | 50 | $0 (2024) |
| Amgen Inc. | $850.18 | 58 | $0 (2024) |
| Merck Sharp & Dohme LLC | $775.71 | 50 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $767.67 | 52 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $661.82 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,363 | 123 | Lilly USA, LLC ($394.17) |
| 2023 | $2,593 | 148 | AbbVie Inc. ($334.90) |
| 2022 | $2,115 | 130 | ABBVIE INC. ($291.26) |
| 2021 | $1,156 | 68 | Novo Nordisk Inc ($154.34) |
| 2020 | $1,073 | 71 | PFIZER INC. ($171.18) |
| 2019 | $1,733 | 122 | PFIZER INC. ($199.18) |
| 2018 | $1,829 | 147 | PFIZER INC. ($216.07) |
| 2017 | $1,914 | 153 | AstraZeneca Pharmaceuticals LP ($289.73) |
All Payment Transactions
962 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Respiratory | ||||||
| 12/13/2024 | Hologic Sales and Service, LLC | APTIMA (Device), THINPREP 2000 PROCESSOR | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Diagnostics | ||||||
| 12/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: UROLOGY | ||||||
| 12/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Oncology | ||||||
| 11/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: PAIN | ||||||
| 11/25/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.04 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Cardio-renal | ||||||
| 10/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Inflammation | ||||||
| 10/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Cardio-renal | ||||||
| 10/21/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: UROLOGY | ||||||
| 10/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Hematology | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Cardio-renal | ||||||
| 09/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: PAIN | ||||||
| 09/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: Cardio-renal | ||||||
| 09/23/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: UROLOGY | ||||||
| 09/20/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $10.72 | General |
| Category: VACCINES | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 2,188 | 3,417 | $545,692 | $211,845 |
| 2022 | 19 | 2,316 | 3,544 | $574,441 | $226,788 |
| 2021 | 22 | 2,536 | 4,953 | $604,781 | $252,133 |
| 2020 | 25 | 2,698 | 5,698 | $551,459 | $233,216 |
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 560 | 1,110 | $167,610 | $66,855 | 39.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 626 | 686 | $150,234 | $56,467 | 37.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 107 | 434 | $64,232 | $26,941 | 41.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 131 | 162 | $67,230 | $21,265 | 31.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 96 | 120 | $26,160 | $10,656 | 40.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 67 | 67 | $19,698 | $7,889 | 40.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 126 | 146 | $13,286 | $5,622 | 42.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 42 | 102 | $8,772 | $3,926 | 44.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 38 | 45 | $6,705 | $2,664 | 39.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 187 | 285 | $4,845 | $2,394 | 49.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 21 | 21 | $2,793 | $1,570 | 56.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $4,811 | $1,343 | 27.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 42 | 42 | $1,680 | $1,270 | 75.6% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 16 | 16 | $1,264 | $1,069 | 84.6% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 21 | 21 | $1,260 | $703.29 | 55.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 51 | 56 | $2,352 | $564.00 | 24.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 57 | $2,280 | $545.00 | 23.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 27 | 30 | $480.00 | $102.30 | 21.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 579 | 1,119 | $168,969 | $70,445 | 41.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 673 | 714 | $156,366 | $60,192 | 38.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 99 | 462 | $68,376 | $26,058 | 38.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 122 | 152 | $63,080 | $23,347 | 37.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 79 | 80 | $23,520 | $10,484 | 44.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 70 | 96 | $20,928 | $7,950 | 38.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 129 | 146 | $13,286 | $5,732 | 43.1% |
About Dr. Mark Brus, MD
Dr. Mark Brus, MD is a Internal Medicine healthcare provider based in Sarasota, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1922097948.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Brus, MD has received a total of $14,777 in payments from pharmaceutical and medical device companies, with $2,363 received in 2024. These payments were reported across 962 transactions from 67 companies. The most common payment nature is "Food and Beverage" ($14,746).
As a Medicare-enrolled provider, Brus has provided services to 9,738 Medicare beneficiaries, totaling 17,612 services with total Medicare billing of $923,982. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Pediatrics
- Location Sarasota, FL
- Active Since 10/21/2005
- Last Updated 06/27/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1922097948
Products in Payments
- JARDIANCE (Drug) $814.69
- Kerendia (Drug) $661.82
- GEMTESA (Drug) $533.23
- Ozempic (Drug) $531.22
- TRELEGY ELLIPTA (Drug) $523.88
- CHANTIX (Drug) $431.89
- UBRELVY (Drug) $394.54
- FARXIGA (Drug) $387.54
- TRULICITY (Drug) $362.65
- NURTEC ODT (Drug) $351.01
- XARELTO (Drug) $343.36
- JANUVIA (Drug) $330.50
- VRAYLAR (Drug) $308.59
- MOUNJARO (Drug) $294.89
- Otezla (Drug) $291.13
- ELIQUIS (Drug) $280.93
- Aimovig (Biological) $268.37
- Cologuard Collection Kit (Device) $250.27
- ENTRESTO (Drug) $244.87
- EMGALITY (Drug) $217.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Sarasota
Brian Betensky, M.d, M.D
Internal Medicine — Payments: $366,466
Dr. Likhitesh Jaikumar, M.d, M.D
Internal Medicine — Payments: $52,659
Dr. Kimberly Lyn Shue, Md, MD
Internal Medicine — Payments: $28,780
Fadi Kayali, M.d, M.D
Internal Medicine — Payments: $25,004
Dr. Frank Corbett, M.d, M.D
Internal Medicine — Payments: $21,591
Garrett Brown, M.d, M.D
Internal Medicine — Payments: $20,583